Paper40596252
The apoptotic and anti-metastatic effects of niosome kaempferol in MCF-7 breast cancer cells.
Minaei S and 2 others. Sci Rep, 2025. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. The apoptotic and anti-metastatic effects of niosome kaempferol in MCF-7 breast cancer cells. Papers, record 40596252. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40596252
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The apoptotic and anti-metastatic effects of niosome kaempferol in MCF-7 breast cancer cells.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Kaempferols | Major topic |
| Apoptosis | Major topic |
| Breast Neoplasms | Major topic |
| Antineoplastic Agents | Major topic |
| Humans | |
| MCF-7 Cells | |
| Female | |
| Nanoparticles | |
| Liposomes | |
| Neoplasm Metastasis |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31371953 | Kaempferol conjugated gold nanoclusters enabled efficient for anticancer therapeutics to A549 lung cancer cells. | Int J Nanomedicine | 2019 | https://conductscience.org/library/papers/31371953 | PubMed |
| 2 | 36557997 | Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways. | Molecules | 2022 | https://conductscience.org/library/papers/36557997 | PubMed |
| 3 | 34514657 | Kaempferol 3-O-gentiobioside, an ALK5 inhibitor, affects the proliferation, migration, and invasion of tumor cells via blockade of the TGF-β/ALK5/Smad signaling pathway. | Phytother Res | 2021 | https://conductscience.org/library/papers/34514657 | PubMed |
| 4 | 35406442 | A Review of the Current Impact of Inhibitors of Apoptosis Proteins and Their Repression in Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35406442 | PubMed |
| 5 | 34510317 | Mechanism of interaction between autophagy and apoptosis in cancer. | Apoptosis | 2021 | https://conductscience.org/library/papers/34510317 | PubMed |
| 6 | 25337553 | Kaempferol Induces Cell Cycle Arrest in HT-29 Human Colon Cancer Cells. | J Cancer Prev | 2013 | https://conductscience.org/library/papers/25337553 | PubMed |
| 7 | 36051855 | Nanotechnology Advances in the Detection and Treatment of Cancer: An Overview. | Nanotheranostics | 2022 | https://conductscience.org/library/papers/36051855 | PubMed |
| 8 | 35752202 | Pro-apoptotic complexes of BAX and BAK on the outer mitochondrial membrane. | Biochim Biophys Acta Mol Cell Res | 2022 | https://conductscience.org/library/papers/35752202 | PubMed |
| 9 | 35062053 | Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35062053 | PubMed |
| 10 | 30402931 | Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive review. | Phytother Res | 2019 | https://conductscience.org/library/papers/30402931 | PubMed |
| 11 | 20016737 | Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells. | Nutr Res Pract | 2008 | https://conductscience.org/library/papers/20016737 | PubMed |
| 12 | 37110140 | Current Understanding of Flavonoids in Cancer Therapy and Prevention. | Metabolites | 2023 | https://conductscience.org/library/papers/37110140 | PubMed |
| 13 | 37047366 | Antiproliferative Mechanisms of a Polyphenolic Combination of Kaempferol and Fisetin in Triple-Negative Breast Cancer Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047366 | PubMed |
| 14 | 36482272 | An update on the pathological classification of breast cancer. | Histopathology | 2023 | https://conductscience.org/library/papers/36482272 | PubMed |
| 15 | 37649675 | Formulation optimization, in vitro and in vivo evaluation of niosomal nanocarriers for enhanced topical delivery of cetirizine. | Saudi Pharm J | 2023 | https://conductscience.org/library/papers/37649675 | PubMed |
| 16 | 19838928 | Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. | Nutr Cancer | 2009 | https://conductscience.org/library/papers/19838928 | PubMed |
| 17 | 37239974 | Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37239974 | PubMed |
| 18 | 36420812 | The anti-cancer effect of chitosan/resveratrol polymeric nanocomplex against triple-negative breast cancer; an in vitro assessment. | IET Nanobiotechnol | 2023 | https://conductscience.org/library/papers/36420812 | PubMed |
| 19 | 19356725 | Downregulation of PLK-1 expression in kaempferol-induced apoptosis of MCF-7 cells. | Eur J Pharmacol | 2009 | https://conductscience.org/library/papers/19356725 | PubMed |
| 20 | 35468008 | Kaempferol: A flavonoid with wider biological activities and its applications. | Crit Rev Food Sci Nutr | 2023 | https://conductscience.org/library/papers/35468008 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958238 | Effects of kaempferol on oxidative stress, cytoskeletal, and cellular features in MCF-7 and MDA-MB-231 breast cancer cells. | BMC Complement Med Ther | 2026 | https://conductscience.org/library/papers/42958238 | PubMed |
| 42927538 | Preparation and characterization of Kaempferol-loaded Niosomes and their effects on apoptosis and cell migration in SKOV3 ovarian cancer cells. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42927538 | PubMed |
| 42811332 | Employing Streptomyces enissocaesilis as a sustainable cell factory for green synthesis of gold nanoparticles with multi-target anticancer activity against MCF-7 breast cancer cells. | Microb Cell Fact | 2026 | https://conductscience.org/library/papers/42811332 | PubMed |
| 42656718 | Dissecting the mechanistic actions of kaempferol in breast and ovarian cancers: pathway-level insights and translational potential. | Front Oncol | 2026 | https://conductscience.org/library/papers/42656718 | PubMed |
| 42518511 | Anticancer Activity and Cell Mechanism of a Novel Flavonoid Derivative from Chrysanthemum × morifolium (Ramat). Hemsl Leaves Against the MCF-7 Breast Cancer Line in vitro. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42518511 | PubMed |
| 42204341 | First evidence for isolation and characterization of Bacopa monnieri (L.) Wettst-derived nanovesicles with anti-neuroblastoma potential. | Sci Rep | 2026 | https://conductscience.org/library/papers/42204341 | PubMed |
| 41986570 | Systematic review on anticancer potential of Kaempferol and quercetin against lung, breast, and colorectal cancers with emphasis on in vitro and in vivo studies. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41986570 | PubMed |
| 41815153 | Rosa roxburghii Tratt fruit polysaccharides inhibit proliferation and induce apoptosis in human cervical cancer cell line. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/41815153 | PubMed |
| 41599661 | Innovations in the Delivery of Bioactive Compounds for Cancer Prevention and Therapy: Advances, Challenges, and Future Perspectives. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41599661 | PubMed |
| 41590097 | Puerarin-Loaded Proniosomal Gel: Formulation, Characterization, In Vitro Antimelanoma Cytotoxic Potential, and In Ovo Irritation Assessment. | Gels | 2026 | https://conductscience.org/library/papers/41590097 | PubMed |
| 41463161 | The Anticancer Effect of Kaempferol Through Downregulation of CDKs and PD-L1 in Triple-Negative Breast Cancer Cells. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41463161 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| ITGA5 | 3678 | PubTator's text mining | https://conductscience.org/library/genes/3678 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40596252
GET https://conductscience.org/api/papers/v1/40596252/references?page=2